[ Back ]   [ More News ]   [ Home ]
Innoviz Reports Fourth Quarter and Full Year 2023 Results, Exceeding Revenue Guidance

TEL AVIV, Israel, Feb. 28, 2024 — (PRNewswire) — Innoviz Technologies Ltd. (Nasdaq: INVZ) (the "Company" or "Innoviz"), a leading Tier-1 direct supplier of high-performance, automotive grade LiDAR sensors and perception software, today provided commercial and strategic updates on its business, reported its financial results for the fourth quarter and full year ended December 31, 2023, and set 2024 commercial and financial targets.

Innoviz Technologies Logo

"I am pleased with our strong finish to 2023, delivering revenues that were above the high end of both our quarterly and annual guidance range," said Innoviz CEO, Omer Keilaf. "The combination of strong revenues and disciplined cost management led to an impressive cash performance with our quarterly cash burn at just $14.5 million, a record low since Innoviz became a public company. I believe this highlights the impact that growing revenues and cost discipline can have on our longer-term financial trajectory."

Keilaf added, "So far in 2024 we have shared exciting news on the customer front, unveiling our second Volkswagen program with the ID. Buzz at CES, and today's news that we are working on an additional InnovizOne deployment with BMW on the 5 Series in China. As we look to the rest of the year ahead, we continue to be very active with our RFI and RFQ pipeline and continue to believe that several additional customer wins are within reach. We continue to believe the LiDAR market will ultimately be a 'winner takes most' industry and that the next few customer decisions could provide us with continued momentum."

Commercial and Strategic Updates

Fourth Quarter 2023 Financial Results

Revenues in Q4 2023 were $14.9 million, up 328% compared to revenues of $3.5 million in Q3 2023 and up 846% compared to revenues of $1.6 million in Q4 2022.  The strong revenue growth came from a combination of NRE services, production units and sample shipments.

Operating expenses in Q4 2023 were $29.5 million, an increase of 6% compared to operating expenses of $27.8 million in Q3 2023, and a year-over-year decrease of 12% compared to $33.5 million in Q4 2022. Operating expenses for Q4 2023 included $5.5 million of share-based compensation compared to $5.3 million of share-based compensation in Q4 2022.

Full Year 2023 Financial Results

Revenues in 2023 were $20.9 million, up 246% compared to revenues of $6.0 million in 2022.  The strong revenue growth resulted from a combination of NRE services, production units and sample shipments, and was partially offset by the transition from sample pricing to production pricing with the BMW program shifting into series production.

Operating expenses in 2023 were $121.0 million, a decline of 3% compared to operating expenses of $124.6 million in 2022. Operating expenses for 2023 included $20.7 million of share-based compensation compared to $19.3 million of share-based compensation in 2022.

Liquidity as of December 31, 2023 consisted of approximately $150.2 million in cash and cash equivalents, short term deposits, short term restricted cash and marketable securities. The combination of stronger revenues and disciplined cost management resulted in the lowest quarter-over-quarter cash burn in the Company's history as a public company at only $14.5 million (net cash used in operating activities and purchase of fixed assets).  

2024 Financial and Operational Targets

The Company is establishing initial targets for Q1 2024 and FY 2024:

After initially guiding 2023 revenue targets too cautiously, Innoviz is shifting to quarterly revenue targets. There are many factors that can influence full year numbers that can be difficult to predict this early in the year, and the Company believes quarterly guidance will ultimately be a more prudent and accurate way to approach revenue targets at this point in the Company's growth curve.

Conference Call

Innoviz management will hold a web conference today, February 28, 2024, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) to discuss commercial and strategic updates, financial results for the fourth quarter and full year 2023 and 2024 financial and operational targets. Innoviz CEO Omer Keilaf and CFO Eldar Cegla will host the call, followed by a question-and-answer session.

Investors are invited to attend by registering in advance here. All relevant information will be sent upon registration.

A replay of the webinar will also be available shortly after the call in the  Investors section of Innoviz's website for 90 days.

About Innoviz Technologies 

Innoviz is a global leader in LiDAR technology, serving as a Tier 1 supplier to the world's leading automotive manufacturers and working towards a future with safe autonomous vehicles on the world's roads. Innoviz's LiDAR and perception software "see" better than a human driver and reduce the possibility of error, meeting the automotive industry's strictest expectations for performance and safety. Operating across the U.S., Europe, and Asia, Innoviz has been selected by internationally recognized premium car brands for use in consumer vehicles as well as by other commercial and industrial leaders for a wide range of use cases. For more information, visit innoviz-tech.com.

Join the discussion: Facebook, LinkedIn, YouTube, Twitter

Media Contact

Email Contact

Investor Contact

Email Contact                                                     

Forward Looking Statements

This announcement contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the services offered by Innoviz, the anticipated technological capability of Innoviz's products, the markets in which Innoviz operates, Innoviz's projected future operational and financial results, including revenue and non-recurring engineering (NRE) bookings. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. "NRE (Non-recuring Engineering) bookings" is booked services that may be ordered from Innoviz usually as part of a program design win and includes, among other things, application engineering, product adaptation services, testing and validation services, standards and qualification work and change requests (usually during the lifetime of a program). The commitment for a certain NRE is usually provided around the design win and may be paid based on milestones over the development phase of the project which may take a few years.

Many factors could cause actual future events, and, in the case of our forward-looking revenue and NRE bookings, actual orders or actual payments, to differ materially from the forward-looking statements in this announcement including but not limited to, the ability to implement business plans, forecasts, and other expectations, the ability to convert design wins into definitive orders and the magnitude of such orders, the possibility that NRE would be set off against liabilities and indemnities, the ability to identify and realize additional opportunities, potential changes and developments in the highly competitive LiDAR technology and related industries, and our expectations regarding the impact of the evolving conflict in Israel to our ongoing operations. The foregoing list is not exhaustive. You should carefully consider such risk and the other risks and uncertainties described in Innoviz's annual report on Form 20-F for the year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission ("SEC") on March 9, 2023, in Innoviz's annual report on Form 20-F for the year ended December 31, 2023 to be filed with the SEC and in other documents filed by Innoviz from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Innoviz assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Innoviz gives no assurance that it will achieve its expectations.

 

 

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

U.S. dollars in thousands (except share and per share data)

(Unaudited)




Year Ended

December 31,


Three Months Ended

December 31,



2023


2022


2023


2022










Revenues

$

20,876

$

6,026

$

14,917

$

1,577

Cost of revenues


(32,490)


(14,790)


(17,197)


(4,113)










Gross loss


(11,614)


(8,764)


(2,280)


(2,536)










Operating expenses:









   Research and development


92,676


95,107


22,107


26,245

   Sales and marketing


8,777


10,300


1,999


2,425

   General and administrative


19,535


19,178


5,412


4,837










Total operating expenses


120,988


124,585


29,518


33,507










Operating loss


(132,602)


(133,349)


(31,798)


(36,043)










Financial income, net


9,790


6,802


1,469


1,950










Loss before taxes on income


(122,812)


(126,547)


(30,329)


(34,093)

Taxes on income


(642)


(325)


(122)


(228)










Net loss

$

(123,454)

$

(126,872)

$

(30,451)

$

(34,321)










Basic and diluted net loss per ordinary share

$

(0.84)

$

(0.94)

$

(0.18)

$

(0.25)










Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share


 

 

147,480,521


135,224,312


 

 

165,121,766


 

 

136,059,472










 

 

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

(Unaudited)




December 31,


December 31,




2023


2022


ASSETS






 CURRENT ASSETS:






Cash and cash equivalents

$

26,283

$

55,718


Short term restricted cash


53


236


Bank deposits


105,750


80,684


Marketable securities


13,335


41,681


Trade receivables, net


7,395


1,762


Inventory


1,868


4,236


Prepaid expenses and other current assets


5,774


3,236


 Total current assets


160,458


187,553








 LONG-TERM ASSETS:






Marketable securities


4,813


7,840


Restricted deposits


2,623


2,543


Property and equipment, net


25,770


30,489


Operating lease right-of-use assets, net


25,486


26,927


Other long-term assets


84


81


 Total long-term assets


58,776


67,880








 Total assets

$

219,234

$

255,433














 LIABILITIES AND SHAREHOLDERS' EQUITY






 CURRENT LIABILITIES:






Trade payables

$

8,036

$

8,367


Deferred revenues


6,949


4,082


Employees and payroll accruals


9,468


8,693


Accrued expenses and other current liabilities


8,743


7,572


Operating lease liabilities


4,034


3,720


 Total current liabilities


37,230


32,434








 LONG-TERM LIABILITIES:






Deferred revenues


-


61


Operating lease liabilities


28,475


30,201


Warrants liability


240


720


 Total long-term liabilities


28,715


30,982








 SHAREHOLDERS' EQUITY:






Ordinary Shares of no-par value


-


-


Additional paid-in capital


788,577


703,851


Accumulated deficit


(635,288)


(511,834)


 Total shareholders' equity


153,289


192,017








 Total liabilities and shareholders' equity

$

219,234

$

255,433














 

 

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollars in thousands

(Unaudited)




Year Ended
December 31,


Three Months Ended
December 31,



2023


2022


2023


2022

Cash flows from operating activities:









Net loss

$

(123,454)

$

(126,872)

$

(30,451)

$

(34,321)

Adjustments required to reconcile net loss to net cash used in operating activities:









Depreciation and amortization


9,192


7,472


3,947


1,543

Remeasurement of warrants liability


(472)


(890)


(128)


(555)

Change in accrued interest on bank deposits


(1,051)


(705)


(709)


(138)

Change in marketable securities


(409)


375


-


(469)

Share-based compensation 


22,320


19,449


6,494


5,352

Capital gain, net


-


(44)


-


(44)

Foreign exchange loss (gain), net


(470)


1,233


(917)


(188)

Change in prepaid expenses and other assets


(782)


(377)


(341)


(88)

Change in trade receivables, net 


(5,633)


(1,249)


(2,523)


(984)

Change in inventory


2,368


20


2,970


472

Changes in operating lease assets and liabilities, net


29


6,530


1,592


1,047

Change in trade payables


424


1,082


368


1,463

Change in accrued expenses and other liabilities


2,578


607


3,122


324

Change in employees and payroll accruals


333


(304)


1,156


(1,186)

Change in deferred revenues


1,974


262


1,400


(72)

Net cash used in operating activities


(93,053)


(93,411)


(14,020)


(27,844)

Cash flows from investing activities:









    Purchase of property and equipment


(6,579)


(22,567)


(481)


(4,828)

    Proceeds from sales of property and equipment


-


54


-


54

Investment in bank deposits


(165,600)


(79,500)


(23,000)


-

Withdrawal of bank deposits


141,500


230,000


29,000


55,000

Investment in restricted deposits


(40)


(2,633)


-


-

Investment in marketable securities


(51,678)


(30,103)


(16,885)


(8,508)

Proceeds from sales and maturities of marketable securities


83,461


30,103


21,586


8,508

Net cash provided by investing activities


1,064


125,354


10,220


50,226

Cash flows from financing activities:









Issuance of ordinary shares, net of issuance cost


61,400


-


(534)


-

Proceeds from exercise of options


456


609


50


102

Net cash provided by (used in) financing activities


61,856


609


(484)


102

Effect of exchange rate changes on cash, cash equivalents and restricted cash


515


 

(1,139)


 

787


 

154

Increase (decrease) in cash, cash equivalents and restricted cash


(29,618)


31,413


(3,497)


22,638

Cash, cash equivalents and restricted cash at the beginning of the period


55,954


24,541


29,833


33,316

Cash, cash equivalents and restricted cash at the end of the period

$

26,336

$

55,954

 

$

26,336

 

$

55,954

 

 

Logo - https://mma.prnewswire.com/media/1496323/Innoviz_Technologies_Logo.jpg

 

Cision View original content: https://www.prnewswire.com/news-releases/innoviz-reports-fourth-quarter-and-full-year-2023-results-exceeding-revenue-guidance-302073976.html

SOURCE Innoviz Technologies

Contact:
Company Name: Innoviz Technologies
+972-74-700-3692
Financial data for Innoviz Technologies